Loading
VB
Viela Bio, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Boundless Meadow Ltd, was filed 25 Oct 2019.
Viela Bio, Inc.: what insiders have been doing
Viela Bio, Inc. is a listed company. Filings by its managers are published through SEC (Form 4). No insider at Viela Bio, Inc. has published a filing in the past twelve months. The most recent one dates from 18 November 2020.
Our records for Viela Bio, Inc. go back to 2019, with 6 purchases and 7 sales on the open market in total.
Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
33
Thresholds
n/a
Buy Volume
€28M
6 ops. · all time
Sell Volume
€53M
7 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2020FY ended December 2020 · cache
Income statement
Revenue10.4M
Net income-134.3M-1293.1% margin
Last declaration on 18 November 2020
Declarations33 total
360,000 shares@ US$47.0069.2% of flowCommon StockSEC:0001104659-20-071034:0
360,000 shares@ US$47.0052.9% of flowCommon StockSEC:0001104659-20-071033:0
360,000 shares@ US$47.00100.0% of flowCommon StockSEC:0001104659-20-071032:0
16,250 shares@ US$5.22100.0% of flowCommon StockSEC:0000899243-20-002306:0
1,882,353 sharesCommon StockSEC:0001104659-19-056278:1
6,800,000 sharesCommon StockSEC:0001104659-19-056278:0
6,800,000 sharesCommon StockSEC:0001104659-19-056280:0
1,882,353 sharesCommon StockSEC:0001104659-19-056280:1
6,800,000 sharesCommon StockSEC:0001104659-19-056270:0
1,882,353 sharesCommon StockSEC:0001104659-19-056270:1
300,000 shares@ US$19.0024.1% of flowCommon StockSEC:0001104659-19-056278:2
Canonical exit: 5 Jan 2020 (T+90)
36,091 shares@ US$22.18013.4% of flowCommon StockSEC:0001104659-19-056278:3
36,091 shares@ US$21.8263.3% of flowCommon StockSEC:0001104659-19-056278:4
Canonical exit: 6 Jan 2020 (T+90)
36,091 shares@ US$22.183.4% of flowCommon StockSEC:0001104659-19-053737:0
36,091 shares@ US$21.833.3% of flowCommon StockSEC:0001104659-19-053737:1
Canonical exit: 6 Jan 2020 (T+90)
1,882,353 sharesCommon StockSEC:0001104659-19-053631:1
14,225,324 sharesCommon StockSEC:0000899243-19-025369:0
6,800,000 sharesCommon StockSEC:0001104659-19-053630:0
1,882,353 sharesCommon StockSEC:0001104659-19-053630:1
1,250,000 sharesCommon StockSEC:0001104659-19-053627:0
6,800,000 sharesCommon StockSEC:0001104659-19-053629:0
1,882,353 sharesCommon StockSEC:0001104659-19-053629:1
25 of 33 declarations
About Viela Bio, Inc.
Viela Bio, Inc. is a biopharmaceutical company focused on developing innovative therapies for autoimmune diseases. It is listed on the XNAS market.
